Tenderwize
Retour à la recherche

Accord de remise pour médicaments à base de tétrabénazine

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Mar 27, 2027 · 126 days left·Open·Supplies·Framework
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Tetrabenazin (ATC-Code N07XX06).

54/100

Score d'opportunité

Needs reviewHigh complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

54 / 100

Complexité

70 / 100

Facteurs de risque

The structured data specifies 27 March 2027 at 11:00, while the XML contains 12:00 and 13:00 local-time entries for the...

The notice refers to contractual documents and conditions, but no extracted contractual documents were provided for ana...

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Niedersachsen. Die Gesundheitskasse.
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Mar 27, 2027

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Conclusion of non-exclusive rebate agreements for tetrabenazine medicinal products under Section 130a(8) SGB V.
  • Open-house model with no selection decision and uniform contractual conditions for participating pharmaceutical companies.
Afficher le résumé complet

AOK Niedersachsen offers a non-exclusive open-house rebate agreement for medicinal products containing tetrabenazine (ATC N07XX06) in Germany. Eligible pharmaceutical entrepreneurs may join under uniform, non-negotiable conditions without a selection decision. The agreement may be replaced by exclusive rebate contracts and can end automatically when those contracts enter into force. No contract value or procurement documents were provided in the analyzed data. The structured deadline is 27 March 2027, but the XML contains conflicting time information; the initial deadline for participation from 1 June 2025 was 24 April 2025.

Risques

The structured data specifies 27 March 2027 at 11:00, while the XML contains 12:00 and 13:00 local-time entries for the...

The notice refers to contractual documents and conditions, but no extracted contractual documents were provided for ana...

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • The participant must be a pharmaceutical entrepreneur within the meaning of Section 4(18) AMG, or a contractual association of pharmaceutical entrepreneurs, in relation to the...
  • A pharmaceutical entrepreneur must have its registered seat in Germany, another EU Member State, or another EEA contracting state in order to place medicinal products on the...
  • Local representatives may participate only if they themselves qualify as pharmaceutical entrepreneurs for the relevant medicinal products.

Critères d'attribution

Lot 1

Price is the stated award criterion; no description or weighting is provided.

Acheteur

Localisation

Hannover, DEU

Identifiant

AOK- Niedersachsen. Die Gesundheitskasse

Activité

Health

Lots (1)

LOT-0000

Tetrabenazine non-exclusive rebate agreement

Non-exclusive open-house rebate agreement under Section 130a(8) SGB V for medicinal products containing tetrabenazine, ATC code N07XX06. Contracts may be concluded with all interested eligible pharmaceutical companies under uniform conditions. Contract terms may last up to 24 months, with all agreements ending no later than 31 May 2027. The lot information is derived from the structured notice and XML notice.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE929, Germany

Durée

May 2025 - May 2027

Catégorie

Pharmaceutical products

Critères d'attribution

Price

Date limite

Deadline Mar 27, 2027

Détails de la procédure

Date de publication
03 Apr 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
217096-2025

Appels d'offres similaires

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy